Review on the association of Group BStreptococcuscapsular antibody and protection against invasive disease in infants

Maternal Antibody at Delivery Protects Neonates From Early Onset Group B Streptococcal Disease

(2013) C. J. Baker et al.   JOURNAL OF INFECTIOUS DISEASES

Epidemiology of Group B Streptococcus in developing countries

(2013) Atul Kumar Johri et al.   VACCINE

Considerations for a phase-III trial to evaluate a group B Streptococcus polysaccharide-protein conjugate vaccine in pregnant women for the prevention of early- and late-onset invasive disease in young-infants

(2013) Shabir A. Madhi et al.   VACCINE

Persistence of functional antibodies to group B streptococcal capsular polysaccharides following immunization with glycoconjugate vaccines

(2012) Morven S. Edwards et al.   VACCINE

Preventing the broad spectrum of perinatal morbidity and mortality through group B streptococcal vaccination

(2012) Morven S. Edwards et al.   VACCINE

Intrapartum antibiotic prophylaxis for the prevention of perinatal group B streptococcal disease: Experience in the United States and implications for a potential group B streptococcal vaccine

(2012) Stephanie J. Schrag et al.   VACCINE

Bacterial Meningitis in the United States, 1998–2007

(2011) Michael C. Thigpen et al.   NEW ENGLAND JOURNAL OF MEDICINE

The Burden of Invasive Early-onset Neonatal Sepsis in the United States, 2005–2008

(2011) Emily J. Weston et al.   PEDIATRIC INFECTIOUS DISEASE JOURNAL

Immunogenicity and physico-chemical characterisation of a candidate conjugate vaccine against group B streptococcus serotypes Ia, Ib and III

(2011) Lorna Lancaster et al.   VACCINE

Bactericidal antibody is the immunologic surrogate of protection against meningococcal disease

(2009) Carl E. Frasch et al.   VACCINE